Wolters Kluwer new integration tool

Share this article:

A new service from Wolters Kluwer Health integrates several of the marketing research firm's data points into a single source, offering financial analysts and brand managers a new forecasting capability. 
The product, inThought, was developed in order to streamline forecasting capabilities for drugmakers, to help them understand where developmental drugs, medical devices and therapies are positioned in the market, and what sort of splash they could make in the future.


"With research headcounts down, there's a fundamental shift in the way analysts and pharma customers want their research delivered," said Ben Weintraub, director of research, in a statement. "Rather than simply striving to offer more data faster, our approach sifts through the clutter to synthesize what is truly important."


Clients can use the tool for monitoring global drug developments, and tap into forecasts of approval models for over 300 drugs in development.

Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Antidote: On Cystic Fibrosis treatments

Antidote: On Cystic Fibrosis treatments

Recent treatments in CF, including the inhaled antibiotic Tobramycin, have increased lifespan well into adulthood.

The $3 generic and the $1,000 pill: pharma outsiders just don't get it

The $3 generic and the $1,000 pill: pharma ...

What do you call the people who treat medical breakthroughs as if they were bank heists? Malicious? Uninformed? Not with it?

Leadership Exchange Uncut : The Agency-Client Relationship

Leadership Exchange Uncut : The Agency-Client Relationship

Click the above link to access MM&M's first Leadership Exchange Uncut e-book, "The Agency-Client Relationship"